Type III Hyperlipoproteinemia: Diagnosis in Whole Plasma by Apolipoprotein-E Immunoassay
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Because the cholesterol-rich very low density (VLD) lipoproteins of subjects with type III hyperlipoproteinemia are distinctively enriched in apolipoprotein E, a radial immunodiffusion assay for apolipoprotein E in whole plasma was developed. Its diagnostic usefulness was tested in randomly selected (n = 174) and hyperlipidemic (n = 61) subsets of an adult employee population and a hyperlipidemia clinic referral group (n = 63), which included 18 patients with well-documented type III hyperlipoproteinemia. Apolipoprotein-E levels were normally distributed among the random population subset, were equal between the two sexes, and increased little with age. The mean and 99th percentile values were 24.6 and 40.1 mg/dl, respectively. All subjects with type III patterns as assigned by standard criteria from both population (n = 4) and referral sources exceeded this 99th percentile (chi +/- SD = 54.7 +/- 9.7 mg/dl). Hence a plasma apolipoprotein-E concentration exceeding 40 mg/dl appears diagnostic of type III hyperlipoproteinemia, representing the first application of an apolipoprotein immunoassay to improved diagnosis of the hyperlipoproteinemias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, T. W., & Darling, D. A. (1954) · Journal of the American Statistical Association · doi:10.1080/01621459.1954.10501232 · Cited by 2,450
Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107334 · Cited by 484
Self-citationUtermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337
Havel, R. J., & Kane, J. P. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.2015 · Cited by 231
Cited by
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Lipoprotein apoprotein metabolism.
Schaefer, E. J., Eisenberg, S., & Levy, R. I. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41267-2 · Cited by 385
Type III Hyperlipoproteinemia Associated with Apolipoprotein E Deficiency
Ghiselli, G., Schaefer, E. J., Gascon, P., & Breser, H. B. (1981) · Science · doi:10.1126/science.6795720 · Cited by 274
Apolipoprotein E synthesis in human kidney, adrenal gland, and liver
Blue, M. L., Williams, D. L., Zucker, S., Khan, S. A., & Blum, C. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.283 · Cited by 226
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38060-3 · Cited by 174
Metadata
- Authors
- KUSHWAHA, R. S., HAZZARD, W. R., WAHL, P. W., & HOOVER, J. J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1977-11-01
- Volume
- 87
- Issue
- 5
- Pages
- 509-516
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2048117444
- Cited by
- 69
- References
- 4
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type III Hyperlipoproteinemia: Diagnosis in Whole Plasma by Apolipoprotein-E Immunoassay. https://app.cochat.ai/papers/10.7326/0003-4819-87-5-509
- The paper
- KUSHWAHA, R. S., HAZZARD, W. R., WAHL, P. W., & HOOVER, J. J. (1977). Type III Hyperlipoproteinemia: Diagnosis in Whole Plasma by Apolipoprotein-E Immunoassay. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-87-5-509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.